Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1595888 NEW YORK, NY
Back to ACAD Full portfolio

Position in ACAD

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$17,880,677
+$17,880,677 QoQ
Shares Held
803,265
Ownership
0.469%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Derivatives in ACAD

reported options exposure · as of Mar 31, 2026
CallValue
$868,140
CallShares
39,000
PutValue
$870,366
PutShares
39,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. ACAD ranks #17 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,757,672 $130,524,721
2 RPRX
Royalty Pharma plc
 2,400,382 $115,146,324
3 TGTX
Tg Therapeutics, Inc.
 2,041,669 $67,824,242
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 122,946 $54,900,305
5 HALO
Halozyme Therapeutics, Inc.
 831,707 $53,753,223
6 EXEL
Exelixis, Inc.
 1,087,030 $46,622,715
7 JAZZ
Jazz Pharmaceuticals plc
 223,615 $42,274,415
8 BNTX
BioNTech SE
 336,757 $29,930,962

All Filings in ACAD

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $868,140 39,000
2026-03-31 $870,366 39,100
2026-03-31 $17,880,677 803,265
2025-12-31 $435,373 16,300
2025-12-31 $462,083 17,300
2025-09-30 $535,634 25,100
2025-09-30 $298,993 14,011
2025-09-30 $1,156,628 54,200
2025-06-30 $258,840 12,000
2025-06-30 $1,156,152 53,600
2025-03-31 $461,209 27,767
2025-03-31 $255,794 15,400
2025-03-31 $219,252 13,200
2024-12-31 $691,795 37,700
2024-12-31 $7,790,546 424,553
2024-09-30 $2,083,251 135,452
2024-09-30 $256,846 16,700
2024-06-30 $8,096,155 498,225
2024-03-31 $6,953,367 376,061
2023-12-31 $13,974,184 446,317
2023-09-30 $6,626,347 317,963
2023-06-30 $2,708,337 113,083
2023-03-31 $2,227,855 118,377
2022-12-31 $221,669 13,924
2022-09-30 $1,091,931 66,744
2022-06-30 $866,506 61,498
2022-03-31 $2,351,762 97,100
2022-03-31 $2,152,575 88,876
2022-03-31 $1,891,582 78,100
2021-12-31 $3,818,424 163,600
2021-12-31 $5,041,440 216,000
2021-12-31 $3,299,387 141,362
2021-09-30 $602,943 36,300
2021-09-30 $994,639 59,882
2021-09-30 $1,073,006 64,600
2021-06-30 $2,058,516 84,400
2021-06-30 $2,020,540 82,843
2021-06-30 $3,017,043 123,700
2021-03-31 $1,831,800 71,000
2021-03-31 $14,030,040 543,800
2021-03-31 $3,786,975 146,782
2020-12-31 $4,068,306 76,100
2020-12-31 $3,923,535 73,392
2020-12-31 $2,320,164 43,400
2020-09-30 $4,331,250 105,000
2020-09-30 $3,309,281 80,225
2020-09-30 $1,938,750 47,000
2020-06-30 $12,515,341 258,208
2020-06-30 $1,095,422 22,600
2020-06-30 $853,072 17,600

Report a Problem

Category
Description
Email (optional, for follow-up)